🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
62 medicines starting with “U”
MedicineActive substanceLicence holderStatus
Ucedane 200 mg dispersible tablets
EU/1/17/1202/001-002
Carglumic acid Eurocept International BV
Ulipristal Acetate Rowex 30 mg film-coated tablets
PA0711/292/001
Ulipristal acetate Rowex Limited, Marketed
Ultibro Breezhaler 85 micrograms/43 micrograms inhalation powder hard capsules
EU/1/13/862/001-006
Indacaterol maleate, Glycopyrronium bromide Novartis Europharm Limited
Ultiva 1 mg Powder for Concentrate for Solution for Infusion
PA1691/032/001
Remifentanil hydrochloride Aspen Pharma Trading Limited Marketed
Ultiva 2 mg Powder for Concentrate for Solution for Infusion
PA1691/032/002
Remifentanil Aspen Pharma Trading Limited Marketed
Ultiva 5 mg Powder for Concentrate for Solution for Infusion
PA1691/032/003
Remifentanil Aspen Pharma Trading Limited Marketed
Ultomiris 1 100 mg/11 mL concentrate for solution for infusion
EU/1/19/1371/003
RAVULIZUMAB Alexion Europe S.A.S.
Ultomiris 300 mg/3 mL concentrate for solution for infusion
EU/1/19/1371/002
RAVULIZUMAB Alexion Europe S.A.S.
Ultra-TechneKow FM 2.15-43.00 GBq radionuclide generator
PA0690/017/001
Sodium molybdate (99mo) Curium Netherlands B.V. Marketed
Ultraproct 0.92 mg/g + 0.9 5mg/g + 5 mg/g Rectal Ointment
PA22650/004/001
Fluocortolone pivalate, Fluocortolone caproate, Cinchocaine Hydrochloride Karo Pharma AB Marketed
Ulunar Breezhaler 85 micrograms/43 micrograms inhalation powder hard capsules
EU/1/14/917/001-006
Indacaterol maleate, Glycopyrronium bromide Novartis Europharm Limited
Uniflu Plus with Vitamin C Tablets
PA1113/006/001
Paracetamol, Codeine phosphate hemihydrate, Diphenhydramine hydrochloride, Phenylephrine hydrochloride, Caffeine Phoenix Labs Marketed
Uniflu with Vitamin C Tablets
PA1113/005/001
Caffeine, Diphenhydramine hydrochloride, Paracetamol, Phenylephrine hydrochloride, Ascorbic acid Phoenix Labs Marketed
UNIPHYLLIN 200 mg Prolonged-Release Tablets
PA23369/003/001
Theophylline Ennogen Healthcare (Europe) Limited Not marketed
UNIPHYLLIN 300 mg Prolonged-Release Tablets
PA23369/003/002
Theophylline Ennogen Healthcare (Europe) Limited Not marketed
UNIPHYLLIN 400 mg Prolonged-Release Tablets
PA23369/003/003
Theophylline Ennogen Healthcare (Europe) Limited Not marketed
Uplizna 100 mg concentrate for solution for infusion
EU/1/21/1602/001
Inebilizumab Amgen Europe B.V.,
Upstaza 2.8 × 10^11 vector genomes/0.5 mL solution for infusion
EU/1/22/1653/001
Eladocagene Exuparvovec PTC Therapeutics International Limited
Uptravi 100 microgram film-coated tablets
EU/1/15/1083/012-013
Selexipag Janssen-Cilag International NV
Uptravi 1000 microgram film-coated tablets
EU/1/15/1083/007
Selexipag Janssen-Cilag International NV
Uptravi 1200 microgram film-coated tablets
EU/1/15/1083/008
Selexipag Janssen-Cilag International NV
Uptravi 1400 microgram film-coated tablets
EU/1/15/1083/009
Selexipag Janssen-Cilag International NV
Uptravi 1600 microgram film-coated tablets
EU/1/15/1083/010
Selexipag Janssen-Cilag International NV
Uptravi 200 microgram film-coated tablets
EU/1/15/1083/001-003
Selexipag Janssen-Cilag International NV
Uptravi 400 microgram film-coated tablets
EU/1/15/1083/004
Selexipag Janssen-Cilag International NV
Uptravi 600 microgram film-coated tablets
EU/1/15/1083/005
Selexipag Janssen-Cilag International NV
Uptravi 800 microgram film-coated tablets
EU/1/15/1083/006
Selexipag Janssen-Cilag International NV
Urispas 200 mg Film-coated Tablets
PA1404/001/001
Flavoxate hydrochloride Recordati Ireland Limited Marketed
Urografin 30 % w/v Solution for infusion
PA1410/012/001
Sodium amidotrizoate, Meglumine amidotrizoate, Sodium hydroxide Bayer Limited Marketed
Uromitexan 100mg/ml Solution for Injection or Infusion
PA2299/024/001
Mesna Baxter Holding B.V. Marketed
Uromitexan tablets 400 mg
PA2299/024/002
Mesna Baxter Holding B.V. Marketed
Uromitexan Tablets 600mg
PA2299/024/003
Mesna Baxter Holding B.V. Marketed
Urorec 4 mg hard capsules
EU/1/09/608/1-7
Silodosin Recordati Ireland Limited
Urorec 8 mg hard capsules
EU/1/09/608/8-14
Silodosin Recordati Ireland Limited
Ursodeoxycholic Acid 250 mg capsules, hard
PA1142/018/001
Ursodeoxycholic acid Amdipharm Limited Not marketed
Ursofalk 250 mg hard capsules
PPA0465/183/001
Ursodeoxycholic acid PCO Manufacturing Ltd.
Ursofalk 250 mg Hard Capsules
PA0573/005/001
Ursodeoxycholic acid Dr. Falk Pharma GmbH Marketed
Ursofalk 250 mg Hard Capsules
PPA1463/144/001
Ursodeoxycholic acid IMED Healthcare Ltd.,
Ursofalk 250 mg/5 ml Suspension
PA0573/005/002
Ursodeoxycholic acid Dr. Falk Pharma GmbH Marketed
Ursofalk 500 mg film-coated tablets
PPA0465/183/002
Ursodeoxycholic acid PCO Manufacturing Ltd.
Ursofalk 500 mg film-coated tablets
PPA1463/144/002
Ursodeoxycholic acid IMED Healthcare Ltd.,
Ursofalk 500mg film-coated tablets
PA0573/005/003
Ursodeoxycholic acid Dr. Falk Pharma GmbH Marketed
Ursogrix 250 mg hard capsules
PA22992/002/001
Ursodeoxycholic acid AS Grindeks
Usgena 130 mg concentrate for solution for infusion
EU/1/25/1987/005
Ustekinumab Stada Arzneimittel AG
Usgena 45 mg solution for injection
EU/1/25/1987/001
Ustekinumab Stada Arzneimittel AG
Usgena 45 mg solution for injection in pre-filled syringe
EU/1/25/1987/002
Ustekinumab Stada Arzneimittel AG
Usgena 90 mg solution for injection in pre-filled syringe
EU/1/25/1987/003-004
Ustekinumab Stada Arzneimittel AG
Usrenty 130 mg concentrate for solution for infusion
EU/1/25/1973/004
Ustekinumab Biocon Biologics Ireland Limited
Usrenty 45 mg solution for injection
EU/1/25/1973/001
Ustekinumab Biocon Biologics Ireland Limited
Usrenty 45 mg solution for injection in pre-filled syringe
EU/1/25/1973/002
Ustekinumab Biocon Biologics Ireland Limited
1 2
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 19 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.